Dallas, TXNCT07657234Now EnrollingIRB Ready

Late Life Depression (LLD) Clinical Trial in Dallas, TX

Access cutting-edge late life depression (lld) treatment through this phase 1/2 clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.

Sponsored by Andre Russowsky Brunoni

Quick Self-Assessment

See if you qualify for this Dallas location

Preparing your pre-screening questions…

Expert Care in Dallas

Access late life depression (lld) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related late life depression (lld) treatment provided free

Apply for This Dallas Location

Check if you qualify for this late life depression (lld) clinical trial in Dallas, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Dallas

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Dallas site if eligible
  4. 4Begin participation

About This Late Life Depression (LLD) Study in Dallas

The purpose of this research study is to determine the effectiveness of Transcranial direct current stimulation (tDCS) therapy in the treatment of participants with Late-life depression (LLD). The study will evaluate feasibility, safety, and tolerability of high-dose (6mA) bilateral tDCS delivered as three daily sessions, 3 times a week, for 3 weeks in older adults (60 y/o and older) with late-life depression.

Sponsor: Andre Russowsky Brunoni

Who Can Participate

Inclusion Criteria

Participants must meet all of the following criteria:
age 60 years or older;
diagnosis of unipolar major depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), confirmed by the Structured Clinical Interview for DSM-5 (SCID-5);
score of 16 or higher on the Quick Inventory of Depressive Symptomology-Clinician Rated (QIDS-C) at screening;
stable antidepressant regimen for at least four weeks prior to enrollment, if applicable;
willingness and capacity to provide informed consent;
Clinical Dementia Rating scale of 0 or 0.5.
availability of an informant who has sufficient knowledge of the participant's daily functioning as ascertained by the study team.

Exclusion Criteria

Participants meeting any of the following criteria will be excluded:
contraindications to tDCS including metallic cranial implants, skin conditions at electrode sites (eczema, open wounds, burns, lesions), or history of adverse reaction to tDCS;
contraindications to magnetic resonance imaging (MRI) including pacemaker, cochlear implants, ferromagnetic implants, or claustrophobia;
depressive disorder due to a medical condition;
psychotic depression;
history of seizures or epilepsy;
bipolar disorder;
psychotic disorders;
severe personality disorder;
active substance use disorder within the past six months or history of substance induced mood or psychotic disorder;
neuromodulation treatment including electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), tDCS, or vagus nerve stimulation (VNS) within the past six months;
active suicidal ideation with plan or intent requiring a higher level of care;
concurrent use of medications that substantially lower seizure threshold;
a clinically established diagnosis of dementia as reported in the participant's health record or scoring 1 or above on CDR;
medically unstable in the clinical opinion of the principal investigators.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Dallas?

Yes, this clinical trial (NCT07657234) has an active research site in Dallas, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Late Life Depression (LLD) Treatment Options in Dallas, TX

If you're searching for late life depression (lld) treatment options in Dallas, TX, this clinical trial (NCT07657234) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Dallas research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced late life depression (lld) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all late life depression (lld) clinical trials near you to find additional studies recruiting in your area.

More Depression Trials in Dallas, TX

See all depression clinical trials recruiting in Dallas — not just this study.

Browse Depression Trials in Dallas →

Browse More Trials by Condition

Depression TrialsAll Conditions →

Ready to Join in Dallas?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Dallas, TX